| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Department of Medicine, University of Western Australia, Fremantk Hospital (A.J.F, M.-H.Z, D.J.R., J.M.B., G.C.N.) Fremantle, Western. Australia 6160;
St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne (B.E.K., J.M.M., T.J.M.) Fitzroy, Victoria 3065;
the Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital (G.N.KJ, Nedlands Western Australia 6009, Australia
Address requests for reprints to: Dr. Anna J. Fenton, Department of Medicine, University of Melbourne, Geelong Hospital, Geelong, Victoria 3220, Australia.
Abstract
PTH-related protein (PTHrP) interacts, via its amino-terminal 34 residues, with PTH receptors on osteoblasts to stimulate osteoclastic bone resorption indirectly. We now report that mature hPTHrP-f 1-141) (EC50, -l0-11 M) and a carboxyl-terminal fragment, PTHrP-(107–139) (EC50, -10-15 M), are potent inhibitors of resorption in an isolated rat osteoclast bone resorption assay, whereas hPTHrP-(l–108) and hPTHrP-(1–34) are inactive in this respect. PTHrP-(107–139) also inhibits resorption in a rat long bone organ culture system and reduces osteoclast spreading. PTHrP-(107–139) does not act on osteoclasts via a cAMP signal transduction mechanism, but its effects may be mediated by protein kinase-C. This previously unrecognized action of PTHrP, to inhibit osteoclastic bone resorption directly, indicates that PTHrP may be a precursor of multiple biologically active peptides with differing physiological functions. (Endocrinology 129: 1762–1768, 1991)
Footnotes
* This work was supported by grants from the University of Western Australia, the Anti-Cancer Council of Victoria, and the National Health and Medical Council of Australia.
Recipient of an Eric Cyril Lawrence Medical Research Fellowship.
Received May 17, 1991.
This article has been cited by other articles:
![]() |
N. Fiaschi-Taesch, K. K. Takane, S. Masters, J. C. Lopez-Talavera, and A. F. Stewart Parathyroid Hormone-Related Protein as a Regulator of pRb and the Cell Cycle in Arterial Smooth Muscle Circulation, July 13, 2004; 110(2): 177 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guillen, P. Martinez, A. R. de Gortazar, M. E. Martinez, and P. Esbrit Both N- and C-terminal Domains of Parathyroid Hormone-related Protein Increase Interleukin-6 by Nuclear Factor-kappa B Activation in Osteoblastic Cells J. Biol. Chem., July 26, 2002; 277(31): 28109 - 28117. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. de Miguel, N. Fiaschi-Taesch, J. C. Lopez-Talavera, K. K. Takane, T. Massfelder, J.-J. Helwig, and A. F. Stewart The C-Terminal Region of PTHrP, in Addition to the Nuclear Localization Signal, Is Essential for the Intracrine Stimulation of Proliferation in Vascular Smooth Muscle Cells Endocrinology, September 1, 2001; 142(9): 4096 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. ValIn, C. Guillen, and P. Esbrit C-Terminal Parathyroid Hormone-Related Protein (PTHrP) (107-139) Stimulates Intracellular Ca2+ through a Receptor Different from the Type 1 PTH/PTHrP Receptor in Osteoblastic Osteosarcoma UMR 106 Cells Endocrinology, July 1, 2001; 142(7): 2752 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. ESBRIT, M. V. ALVAREZ-ARROYO, F. DE MIGUEL, O. MARTIN, M. E. MARTINEZ, and C. CARAMELO C-Terminal Parathyroid Hormone-Related Protein Increases Vascular Endothelial Growth Factor in Human Osteoblastic Cells J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1085 - 1092. [Abstract] [Full Text] |
||||
![]() |
G. J. Strewler The Physiology of Parathyroid Hormone-Related Protein N. Engl. J. Med., January 20, 2000; 342(3): 177 - 185. [Full Text] [PDF] |
||||
![]() |
F. DE MIGUEL, P. MARTINEZ-FERNANDEZ, C. GUILLEN, A. VALIN, A. RODRIGO, M. E. MARTINEZ, and P. ESBRIT Parathyroid Hormone-Related Protein (107-139) Stimulates Interleukin-6 Expression in Human Osteoblastic Cells J. Am. Soc. Nephrol., April 1, 1999; 10(4): 796 - 803. [Abstract] [Full Text] |
||||
![]() |
M. H. C. Lam, L. J. Briggs, W. Hu, T. J. Martin, M. T. Gillespie, and D. A. Jans Importin beta Recognizes Parathyroid Hormone-related Protein with High Affinity and Mediates Its Nuclear Import in the Absence of Importin alpha J. Biol. Chem., March 12, 1999; 274(11): 7391 - 7398. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kovacs and H. M. Kronenberg Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation Endocr. Rev., December 1, 1997; 18(6): 832 - 872. [Abstract] [Full Text] |
||||
![]() |
J. Cornish, K. E. Callon, G. C. Nicholson, and I. R. Reid Parathyroid Hormone-Related Protein-(107-139) Inhibits Bone Resorption in Vivo Endocrinology, March 1, 1997; 138(3): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Plawner, W. M. Philbrick, W. J. Burtis, A. E. Broadus, and A. F. Stewart Cell Type-specific Secretion of Parathyroid Hormone-related Protein via the Regulated versus the Constitutive Secretory Pathway J. Biol. Chem., June 9, 1995; 270(23): 14078 - 14084. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |